Farrugia Albert
Medical School, The University of Western Australia, Perth, Australia.
Haemophilia. 2025 Sep;31(5):811-814. doi: 10.1111/hae.70116. Epub 2025 Aug 25.
This commentary addresses issues raised during the infected blood inquiry (IBI) which ran for 6 years before concluding in 2024. Reference is made to publications in issues of Haemophilia and other journals, addressing the outcomes of the IBI from various perspectives. The author draws on his personal experience, as a patient who also made a career as a plasma fractionation scientist, to critique some of the IBI's salient conclusions. The commentary seeks to let the dust settle around the IBI by including features which have been inadequately addressed, in the author's view as a participant in the events covered by the inquiry.
本评论探讨了在感染血液调查(IBI)期间提出的问题,该调查历时6年,于2024年结束。文中引用了《血友病》及其他期刊上的出版物,从不同角度阐述了IBI的结果。作者凭借其作为患者以及血浆分离科学家的个人经历,对IBI的一些重要结论进行了批判。作为调查所涉事件的参与者,作者认为本评论旨在通过纳入一些未得到充分探讨的内容,使围绕IBI的讨论尘埃落定。